Navigation Links
Researchers find alternative cholesterol-lowering drug for patients who can't tolerate statins
Date:3/11/2013

of pitavastatin.

  • Pitavastatin lowered cholesterol by an average of 34 percent.

  • Patients who could best tolerate the drug were males with no history of heart disease or diabetes.

    "We're excited about these findings," said Dr. Muhlestein. "If patients are having a hard time taking older statins, they should try this newer option. We believe the side effects of this drug differ from other statins because pitavastatin is water-soluble and metabolizes differently."

    The Intermountain study also confirmed that pitavastatin is far more effective than any other non-statin option.

    Ezetimibe (Zetia), for example, is a drug that blocks the absorption of cholesterol and is a non-statin treatment option, but it only lowers bad cholesterol by 18 to 20 percent. Another option is healthy margarine, but that only lowers it by 5 to 10 percent. Pitavastatin, by contrast, lowered cholesterol by an average of 34 percent, according to the study.


    '/>"/>


  • Contact: Jess C. Gomez
    jess.gomez@imail.org
    801-718-8495
    Intermountain Medical Center
    Source:Eurekalert

    Page: 1 2

    Related biology news :

    1. Researchers develop tools for discovering new species
    2. University of Illinois researchers develop AFM-IR for nanometer scale chemical identification
    3. IRB Barcelona researchers discover mechanism that regulates steroid hormone production in Drosophila
    4. Researchers discover gateway in nucleus has a second important job no one noticed before
    5. Researchers explain a key developmental mechanism for the first time in plants
    6. Researchers find molecular switch turning on self-renewal of liver damage
    7. UGA researchers shed light on ancient origin of life
    8. Researchers discover workings of brains GPS system
    9. Researchers propose new solution to ensure biofuel plants dont become noxious weeds
    10. Temple researchers discover key to heart failure, new therapies on horizon
    11. Researchers discover gene that causes obesity in mice
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/15/2014)... pairs, researchers from the Bloomberg School of Public ... reuptake inhibitors (SSRIs), a frequently prescribed treatment for ... autism spectrum disorder (ASD) and developmental delays (DD) ... edition of Pediatrics , analyzed data from ... population-based controls, where a uniform protocol was implemented ...
    (Date:4/15/2014)... who study the deadliest infectious diseases recognized the contributions ... at the University of Texas Medical Branch, with a ... on Filoviruses. The filoviruses include Ebola and Marburg viruses ... people infected. The current outbreak of Ebola virus raging ... so far. , "This award represents the culmination ...
    (Date:4/15/2014)... form could help reduce side effects by targeting the ... have developed nanoparticles that deliver one or two chemotherapy ... particles that can carry any more than that in ... a new way to build such nanoparticles, making it ... In a paper published in the Journal of ...
    Breaking Biology News(10 mins):Study: SSRI use during pregnancy associated with autism and developmental delays in boys 2International research group recognizes UTMB experts 2International research group recognizes UTMB experts 3Targeting cancer with a triple threat 2Targeting cancer with a triple threat 3
    ... held its breath when the tanker Jessica, loaded with 150,000 ... in the heart of one of the most precious, famous ... At risk were vast numbers of unique species of flora ... to his landmark theory of evolution by natural selection. ...
    ... policy-makers, business leaders and environmentalists are joining forces to ... taking part in an influential new forum at the ... February 22, the Nitrous Oxide Focus Group will engage ... Marks & Spencer, British Sugar, Defra, the Country Land ...
    ... , Imagine a gigantic, inflatable, sausage-like bag capable of ... equivalent of 2.2 days of current global emissions. Now try ... radius and several kilometres long, resting benignly on the seabed ... first blush, this might appear like science fiction, but its ...
    Cached Biology News:First wind turbines on Galapagos Islands will halve diesel imports, reduce risk of future oil spills 2First wind turbines on Galapagos Islands will halve diesel imports, reduce risk of future oil spills 3First wind turbines on Galapagos Islands will halve diesel imports, reduce risk of future oil spills 4Nitrous oxide: definitely no laughing matter 2Into the abyss: Deep-sixing carbon 2
    (Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
    (Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
    (Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
    (Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
    Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
    ... SAN DIEGO , Feb. 16 BioMed Realty ... of an amendment to its lease with Ironwood Pharmaceuticals, Inc. (Nasdaq: ... in Cambridge, Massachusetts .  Ironwood has agreed to lease an ... its existing premises located in the heart of the Kendall Square ...
    ... , SAN FRANCISCO , Feb. 16 ... showcase innovative new initiatives at Informex this week, highlighting the ... to the global chemicals industry. , At Informex 2010, ... between seven leading universities, the private sector and the Scottish ...
    ... PLEASANTON, Calif. , Feb. 16 ... proprietary chemistry for nucleic acid testing applications that are relevant ... for the "Most Promising Company" award at the Personalized Medicine ... The PMWC 2010 was created to examine the emerging field ...
    Cached Biology Technology:BioMed Realty Trust Expands Lease With Ironwood Pharmaceuticals for 50,000 Square Feet in Cambridge, Massachusetts 2BioMed Realty Trust Expands Lease With Ironwood Pharmaceuticals for 50,000 Square Feet in Cambridge, Massachusetts 3BioMed Realty Trust Expands Lease With Ironwood Pharmaceuticals for 50,000 Square Feet in Cambridge, Massachusetts 4Scotland Launches Chemicals Industry Partnerships To Propel $13 Billion Sector 2Scotland Launches Chemicals Industry Partnerships To Propel $13 Billion Sector 3Scotland Launches Chemicals Industry Partnerships To Propel $13 Billion Sector 4QuantaLife, Inc. Unanimously Selected as the 'Most Promising Company' at the Personalized Medicine World Conference 2010 2QuantaLife, Inc. Unanimously Selected as the 'Most Promising Company' at the Personalized Medicine World Conference 2010 3QuantaLife, Inc. Unanimously Selected as the 'Most Promising Company' at the Personalized Medicine World Conference 2010 4
    ... coli containing a clone of the human Topoisomerase ... II alters the topological state of nucleic acids ... transient break which generates a separate DNA helix ... DNA passage mechanism, the enzyme can relax negatively ...
    RNase-Free DNase 50 l...
    supplied with 10x reaction buffer...
    ... RNase H degrades, as an endoribonuclease, ... DNA hybrids of natural origin, e.g. ... synthetic complexes, e.g. poly(A) x poly(dT). ... and 3-OH termini. Nearly no activity ...
    Biology Products: